Serum β-hCG as an Indicator for Persistence in Gestational Trophoblastic Neoplasia. The Insight, Dhaka, BD, v. 9, n. 02, p. 476–482, 2026. DOI: 10.5281/zenodo.20741328. Disponível em: https://www.bdjournals.org/insight/article/view/1269. Acesso em: 11 jul. 2026.